Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. Óäàëåíèå âîñüì¸ðêè è ïîñëåäñòâèÿ
    îò Ìàêñèì â ðàçäåëå Ñòîìàòîëîã
    Îòâåòîâ: 4
    : 22.07.2019, 15:01
  2. ïîñëåäñòâèÿ óäàëåíèÿ ìàòêè
    îò Äèëÿ â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 3
    : 07.10.2007, 04:41
  3. Óäàëåíèå âîñüì¸ðêè è ïîñëåäñòâèÿ
    îò Ìàêñèì â ðàçäåëå Õèðóðã
    Îòâåòîâ: 0
    : 17.09.2007, 05:59
  4. ïîñëåäñòâèÿ óäàëåíèÿ êèñòû
    îò Âëàäèñëàâ â ðàçäåëå Óðîëîã-àíäðîëîã
    Îòâåòîâ: 1
    : 21.02.2007, 23:56
  5. Óäàëåíèå ìàòêè. Ïîñëåäñòâèÿ óäàëåíèÿ
    îò Ñåðãåé Ìîòîðèí â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 10
    : 01.09.2004, 20:30
  1. Ñåðãåé Ìîòîðèí
    #1
    ×èòàòåëü Íåäóã.Ðó
    Ãàëèíà (sd1_sn@ukrpost.net) ----- Ãîñïîäà äîêòîðà! Áóäüòå äîáðû îòâåòèòü åñëè â 40 ëåò óäàëèëè ìàòêó è ÿè÷íèêè, òî êàêèì îáðàçîì ýòî ñêàæåòñÿ íà ôèçè÷åñêîì ñîñòîÿíèè, ïðîöåññàõ ñòàðåíèÿ è ïîëîâîé æèçíè. ×òî íåîáõîäèìî ïðèíèìàòü, ÷òîáû èçáåæàòü íåãàòèâíûõ ïîñëåäñòâèé åñëè òàêîâûå èìåþò ìåñòî. Çàðàíåå áëàãîäàðíà. Ãàëèíà

  2. bumka
    #2
    ×èòàòåëü Íåäóã.Ðó
    basic ----- Òîëüêî çàìåñòèòåëüíàÿ ãîðìîíîòåðàïèÿ!

  3. covsh
    #3
    ×èòàòåëü Íåäóã.Ðó
    Íàäåæäà (n_tikhman@mail.ru) ----- Ãîñïîäà ãèíåêîëîãè! Ñèòóàöèÿ òàêàÿ: 6 ëåò íàçàä â 46 ëåò ìîåé ìàìå ñäåëàëè ãèñòåðýêòîìèþ, íàçíà÷èëè çàìåñòèòåëüíóþ ãîðìîíîòåðàïèþ, íî ãîðìîíû îíà ïðèíèìàòü íå ñòàëàïî òåì âðåìåíàì ïî ôèíàíñîâûì ïðè÷èíàì, ñåé÷àñ ñîñòîÿíèå çäîðîâüÿ óäîâëåòâîðèòåëüíîå, èç èçìåíåíèé çà ïîñëåäíèé ãîä ìîãó îòìåòèòü ëèøü õîëåñòåðèíåìèþ, è ïîíèæåííóþ ðàáîòîñïîñîáíîñòü. Çàðàíåå áëàãîäàðíà çà îòâåò íà ñëåäóþùèé âîïðîñ: öåëåñîîáðàçíî ëè ñåé÷àñ íà÷èíàòü ÇÃÒ, åñëè äà, òî êàêèì ïðåïàðàòîì è â êàêèõ äîçàõ?

  4. angelika0801
    #4
    ×èòàòåëü Íåäóã.Ðó
    (Àðáóç) ----- Äà, åé öåëåñîîáðàçíî íà÷èíàòü ÇÃÒ. È óäàëåíèå ìàòêè òóò íå ïðè÷åì. Äëÿ íàçíà÷åíèÿ ÇÃÒ íóæíî îáðàòèòüñÿ ê ãèíåêîëîãó è ïðîéòè îáñëåäîâàíèå. Ïîñëå ýòîãî âðà÷ ñìîæåò ïîäîáðàòü íóæíûé ïðåïàðàò.

  5. Êðîøêà_Ëó
    #5
    ×èòàòåëü Íåäóã.Ðó
    basic ----- À Âû ãîâîðèòå ñîñòîÿíèå óäîâëåòâîðèòåëüíîå. Ïðîéäèòå îáñëåäîâàíèå,è Âû óâèäåòå ,÷òî åñòü êó÷à ìåëî÷åé íà êîòîðûå íå îáðàùàåòå âíèìàíèÿ. Íàâåðíîå Âàøåé ìàìå îñòàâèëè ïðèäàòêè,÷òî â 46 ëåò ïðàêòè÷åñêè íå äåëàþò,íî ÇÃÒ ïðèìåíÿòü íåîáõîäèìî.

  6. Òàòüÿíà Ä.
    #6
    ×èòàòåëü Íåäóã.Ðó
    Ëåíà ----- Óâàæàåìûé basic! Õîòåëîñü áû óçíàòü Âàøå ìíåíèå ïî ïîâîäó âêëþ÷åíèÿ àìåðèêàíñêèìè ýêñïåðòàìè ïîëîâîãî ãîðìîíà ýñòðîãåíà â ñïèñîê êàíöåðîãåíîâ, ïîâûøàþùèõ ðèñê ðàçâèòèÿ ðàêà ìàòêè è ãðóäè, äàæå â ñî÷åòàíèè ñ ïðîãåñòèíàìè. Ñîîáùåíèå áûëî â Associated Press. Ñïàñèáî. Ëåíà

  7. uguriri
    #7
    ×èòàòåëü Íåäóã.Ðó
    Àííà ----- Äëÿ basic: By RANDOLPH E. SCHMID Associated Press Writer WASHINGTON AP - A panel of federal scientific advisers says estrogen should be placed on the nations list of cancer-causing substances, even though it remains a good treatment for many women. The National Toxicology Program advisory committee voted 8-1 that steroidal estrogen _ a type used in post-menopausal treatments and birth control pills _ should be listed because of an association with endometrial cancer and, to a lesser extent, breast cancer. Another type of post-menopausal estrogen, conjugated estrogens, already is on the federal carcinogen list. Doctors already know about the cancer link. Thats the reason post-menopausal estrogen is given together with another hormone called progestin: The combination lowers the risk of endometrial cancer. But the NTP advisers said putting all estrogens on the federal list would help women trying to balance the benefits and risks when choosing hormone therapy. ``Physicians never discuss any of these risks when they are prescribing hormone therapy. They only discuss benefits. Listing might force it on the table, Michelle Medinsky, a toxicologist from Durham, N.C., said before the vote. The committee of scientists advises the NTP, a branch of the National Institutes of Health that every two years updates the federal list of proven and suspected cancer-causing substances. The NTP typically follows its advisers recommendations, but an officially updated carcinogen list isnt expected until 2002. Thursday, after a daylong debate, the panel declined to add talc powder to the list, saying there wasnt enough evidence linking its use in feminine hygiene products to ovarian cancer. The panel deadlocked over whether to a second type of talc, fibrous talc that some studies have linked to lung cancer in talc miners. On Wednesday, the panel voted to add ultraviolet radiation _ those sunburn-causing rays long known to cause skin cancer _ to the official carcinogen list. The panel on Friday continued debating an association between cancers of the nose and sinuses with industrial exposure to wood dust. Talc has long been controversial. When studies first appeared suggesting it migrated into the ovaries to cause tumors, many feminine hygiene products replaced talc with cornstarch. Panelist Medinsky said she had been prepared to list talc powder as ``reasonably believed to cause cancer. But after listening to hours of industry attacks on the science, ``the evidence has knocked me out of the reasonably category into not list, she said before the panel voted 7-3 against listing talc. Talc in one form or the other can be found in many papers, paints, ceramics, food wrappers, hard candy, chewing gum, cosmetics and pills. Most people are familiar with talc as a loose powder used in cosmetics and as a drying powder. Industry officials also attacked studies that showed increased lung cancer in talc miners in New York State and questioned an experiment that showed that rats breathing high concentrations of talc got lung cancer. Higher lung-cancer rates in talc miners may have resulted from their smoking or from the presence of radon gas in the mines or asbestos in soils nearby, industry officials said. The scientific advisers then deadlocked on whether this second type of talc, fibrous talc, caused lung cancer, voting 5-5 on adding it to the carcinogen list. UV light, however, was a no-brainer for the panel, which voted unanimously that it was a known human carcinogen. UV radiation is not visible, but it is felt as heat and can damage the eyes and skin. It comes in three forms, ranging from the relatively long-wavelength UVA to the shortest wavelength UVC. UVA accounts for most of the solar UV radiation because it is not absorbed by the atmosphere. UVB is mostly absorbed by the ozone layer and UVC is totally absorbed. All three are produced by mercury arc sun lamps, while other lamps that simulate sunlight produce primarily UVA.

  8. Remizova Julia
    #8
    ×èòàòåëü Íåäóã.Ðó
    basic ----- ß äóìàþ,÷òî öåëåñîîáðàçíî ïîäãîòîâèòü äëÿ Âàñ è Àííû ñîîáùåíèå î ýñòðîãåíàõ è ïðîãåñòèíàõ è êàíöåðîãåíåçå òîëüêî ìîæíî íà ðóññêîì ÿçûêå,ïîñêîëüêó ïå÷àòàü àíãëèéñêèé ìíå áóäåò ñëîæíî. Çàâòðà ó ìåíÿ äåæóðñòâî â îäíîé áîëüíèöå à ïîñëåçàâòðà â äðóãîé,òàê,÷òî åñëè ÿ óñïåþ äíåì çàëåñòü â èíòåðåíåò ÿ îáÿçàòåëüíî âûñêàæó Âàì ñâîå ìíåíèå ïî äàííîìó âîïðîñó. Êðàòêî õî÷åòñÿ ñêàçàòü ,÷òî ñåãîäíÿ îòíîøåíèå ê ãîðìîíàì è êàíöåðîãåíåçó çíà÷èòåëüíî ïåðåñìàòðèâàþòñÿ è ïîñåäíèå ðàáîòû âîîáùå ãîâîðÿò î òîì,÷òî â äàííîì âîïðîñå ìíîãî ñóáúåêòèâèçìà.Åñëè Âû âåðèòå â êàíöåðîãåíåç - Âû íàéäåòå êàíöåðîãåíåç,åñëè íåò,òî íåò.  ÑØÀ ïðàêòè÷åñêè ìîíîïîëèÿ American Home ïî ÇÃÒ,òàêæå Àìåðèêà èäåò ïî ïóòè èñïîëüçîâàíèÿ Ïðåìàðèíàýñòðîãåíû ïîëó÷åííûå èç ìî÷è æåðåáûõ êîáûëâ êîòîðîì ìíîãî ìåòàáîëèòîâ,äåéñòâèå êîòîðûõ íåâîçìîæíî ó÷åñòü.Åâðîïàñþäà ìîæíî âíåñòè è Ðîññèþ ñ Óêðàèíîéïîêà èäåò ïî ïóòè èñïîëüçîâàíèÿ ÷èñòîãî ýñòðîãåíà b-ýñòðàäèîëà,õîòÿ â Ðîññèè óæå çàðåãèñòðèðîâàí è Ïðåìàðèíïðàâäà Àííà?. Òî,÷òî êàñàåòñÿ ìîëî÷íîé æåëåçû,òî íå õî÷ó Âàñ ðàññòðàèâàòü, íî ãåñòàãåíû èãðàþò ðîëü, â ðàçâèòèè ó÷åíèÿ î ìîëî÷íîé æåëåçå,êóäà áîëåå âåñîìóþ,÷åì ýñòðîãåíû.È ýòîìó ñòàëè ïîÿâëÿòñÿ ïîäòâåðæäåíèÿ. Íàøè çíàíèÿ î ýíäîìåòðèè íåëüçÿ ïåðåíîñèòü íà ìîëî÷íóþ æåëåçó,íî îá ýòîì òîæå ëó÷øå ñïðîñèòü Àííóîíà âñå òàêè ðàáîòàåò â ñòîëèöå,à íå â ïðîâèíöèè,êàê ÿ. Íå çíàþ,ñìîã ëè îòâåòèòü ÿ Âàì,äî âñòðå÷è ïîñëå äåæóðñòâ.Äóìàþ,÷òî ÿ íàïèøó Âàì áîëåå ïîäðîáíî. Àííå.Áîëüøîå ñïàñèáî çà èíôîðìàöèþ. ß ,ê ñîæàëåíèþ ,íå ìîãó áåãëî ÷èòàòü àíãëèéñêèé òåêñò, íî çà ýòè äâà äíÿ ñäåëàþ ïåðåâîä.

  9. Ksenya
    #9
    ×èòàòåëü Íåäóã.Ðó
    Àííà ----- Íàñêîëüêî ÿ ïîíèìàþ, â äàííîé ïóáëèêàöèè ðå÷ü èäåò âñåãî ëèøü î âîçìîæíîñòè âêëþ÷åíèÿ ýñòðîãåíîâ â ñïèñîê êàíöåðîãåíîâ, êîòîðûé áóäåò óòâåðæäåí íå ðàíüøå 2002 ãîäà. ×òî êàñàåòñÿ ýñòðîãåíîâ è ÇÃÒ, òî, äåéñòâèòåëüíî, ïðèåì ÷èñòûõ ýñòðîãåíîâ ïðè èíòàêòíîé ìàòêè çíà÷èòåëüíî ïîâûøàåò ðèñê ðàçâèòèÿ ðàêà ýíäîìåòðèÿ.  òî æå âðåìÿ ýïèäåìèîëîãè÷åñêèå èññëåäîâàíèÿ ïîêàçàëè, ÷òî äîáàâëåíèå ïðîãåñòèíîâ íå ìåíåå 10 äíåé â êàæäîì öèêëå ïîëíîñòüþ íèâåëèðóåò ýòîò ðèñê. Ñ äðóãîé ñòîðîíû, ïðîãåñòèíû â áîëüøåé ñòåïåíè, ÷åì ýñòðîãåíû, ïîâûøàþò ðèñê ðàçâèòèÿ ðàêà ìîëî÷íîé æåëåçû íà 24% â òå÷åíèå êàæäûõ 5 ëåò ïðèìåíåíèÿ. Ïîýòîìó íà ñåãîäíÿøíèé äåíü ñ÷èòàåòñÿ îïòèìàëüíûì êîìáèíèðîâàòü ýñòðîãåíûòàáëåòêè, ïëàñòûðü, ãåëü ñ âíóòðèìàòî÷íûì ââåäåíèåì ïðîãåñòèíîâ ÂÌÑ ñ ëåâîíîðãåñòðåëîì, ïðè ýòîì ïðîãåñòèíû äåéñòâóþò íåïîñðåäñòâåííî íà ýíäîìåòðèé, çàùèùàÿ åãî îò ïðîëèôåðàòèâíîãî âëèÿíèÿ ýñòðîãåíîâ, è íå âëèÿþò íà ìîëî÷íûå æåëåçû, ò. ê. ïðàêòè÷åñêè íå ïîïàäàþò â êðîâîòîê. Pike M. et al. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.Steroids 2000 Oct-Nov;6510-11:659-64 P. S. Ïðåìàðèí â Ðîññèè çàðåãèñòðèðîâàí.

  10. Krav
    #10
    ×èòàòåëü Íåäóã.Ðó
    Çäðàâñòâóéòå!

    Ìíå 49 ëåò.

     29 ëåò, ò.å. â 1982 ã. ìíå áûëà ñäåëàíà îïåðàöèÿ ïî ïîâîäó äåðìîèäíîé êèñòû ïðàâîãî ÿè÷íèêà (ðàçìåð 5,0 X 6,0),

    óäàëåíèå ïðèäàòêîâ, ðåçåêöèÿ ëåâîãî ÿè÷íèêà - â ãîðîäñêîé áîëüíèöå ¹46 Çàâåä. îòä. Î÷àêîâîé Ò.Í. Íûíå ýòà áîëüíèöà íå ñóùåñòâóåò.

    Ñïóñòÿ 8 ëåò, â 1990 ã. â âîçðàñòå 37 ëåò ìíå áûëà ïðîâåäåíà åùå îäíà îïåðàöèÿ ïî ïîâîäó äåðìîèäíîé êèñòû ëåâîãî ÿè÷íèêà (5,8 õ 6,0)

    - Óäàëåíèå ëåâûõ ïðèäàòêîâ, ýêñòåðïàöèÿ ìàòêè â ôèëèàëå á-öû äîêòîðîì Ëåáåäåâûì. (Ïåðåä îïåðàöèåé áûëà îñìîòðåíà ïðîôåññîðîì Â. È. Åëüöîâûì â ïîëèêëèíèêå 4ãî Ãëàâíîãî Óïðàâëåíèÿ ïðè ÌÇ ÐÑÔÑÐ, íûíå òàêæå íå ñóùåñòâóþùåãî).

     ïåðâûå 2-3 ìåñÿöà ïîñëå ïîñëåäíåé îïåðàöèè èíîãäà ïî íî÷àì ÿ îùóùàëà ïðèëèâû æàðîâûõ âîëí. âñêîðå ýòè ÿâëåíèÿ óøëè.

    Ïðîøëî 10 ëåò. Çà ýòè ãîäû ìåíÿ àáñîëþòíî íè÷åãî íå áåñïîêîèëî. Ðåãóëÿðíî, 1 ðàç â ìåñÿö ïðîõîäèëà îñìîòð ó ãèíåêîëîãà, íàáëþäàëàñü ïðè ýòîì â Ìàìîãðàôè÷åñêîì Öåíòðå ñ äèàãíîçîì : Ôèáðîçíî-êèñòîçíàÿ ìàñòîïàòèÿ.

    Íî íà÷èíàÿ ñ 1999 ã., ÿ ïî÷óâñòâîâàëà óõóäøåíèå ñâîåãî ñîñòîÿíèÿ: ïåðåáîè â ðàáîòå ñåðäöà, ñêà÷êè ÀÄ, ïðåðûâíûé ñîí, ñèëüíûå èçíóðÿþùèå ïðèëèâû, îñîáåííî ïî íî÷àì. Ïðèíèìàëà "Êëèìàäåíîí".  ýòîò ïåðèîä ÿ îäíîâðåìåííî ðàáîòàëà íà 2-õ ðàáîòàõ, äà åùå íà ñóòî÷íûõ äåæóðñòâàõ.

     íîÿáðå 2000 ã. áûë ïðèñòóï, êîòîðûé ñîïðîâîæäàëñÿ ïðèñòóïîì òàõèêàðäèè, ñëàáîñòüþ.  ìîìåíò ïðèñòóïà áûë ÷àñòûé æèäêèé ñòóë, ïî÷òè åæåìèíóòíîå ìî÷åèñïóñêàíèå, ïîâûøåíèå ÀÄ, à ãëàâîíå - ðåçêàÿ íåõâàòêà âîçäóõà. Îòêðûòîå îêíî íå ïîìîãàëî, âîçíèê ïàíè÷åñêèé ñòðàõ.

    Òàêîå ïîâòîðÿëîñü åùå äâàæäû, ñ ïåðåðûâàìè â 2-3 íåäåëè.



    Ðåçêî óïàë ãåìîãëîáèí.



    Êîíóëüòèðîâàëàñü ó ãèíåêîëîãà,íåâðîïàòîëîãà, ýíäîêðèíîëîãà, êàðäèîëîãà - âûïèñûâàþò ëåêàðñòâà, ÷òîáû óáðàòü íåïðèÿòíûå ÿâëåíèÿ, à ïðè÷èíó óõóäøåíèÿ ñîñòîÿíèÿ ïî ïðîøåñòâèè ñòîëüêèõ ëåò íàçâàòü íå ìîãóò.



    Íà ñåãîäíÿøíèé ìîìåíò ÿ î÷åíü íóæäàþñü â êâàëèôèöèðîâàííîé ïîìîùè ñïåöèàëèñòà.

    ÏÎÌÎÃÈÒÅ ÏÎÆÀËÓÉÑÒÀ!



    Çàðàíåå Âàì áëàãîäàðíà,

    Ìàðèíà.

  11. vitamina
    #11
    ×èòàòåëü Íåäóã.Ðó
    Ìàðèíà,



    Âàøè ïðîáëåìû ñ ãèíåêîëîãè÷åñêèìè çàáîëåâàíèÿìè íå ñâÿçàíû.



    Âàì ñòîèò áîëåå ïîäðîáíî îïèñàòü òî, ÷òî Âàñ áåñïîêîèò. ß, íàïðèìåð, òàê è íå ïîíÿëà, áûë ëè ó Âàñ îäíîêðàòíûé ýïèçîä èëè ýòî ñîñòîÿíèå âîçíèêàåò ïåðèîäè÷åñêè. À åñëè Âû ãîâîðèòå î ïîâûøåíèè ÀÄ - ñîîáùèòå öèôðû è êàêèå èññëåäîâàíèÿ Âàì áûëè ïðîâåäåíû + íîðìû ëàáîðàòîðèé.



    ñ óâàæåíèåì,

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •